Repositório de dados e outros materiais relacionados com artigos em processo de avaliação para publicação ou publicados pelo periódico Revista do Instituto de Medicina Tropical de São Paulo.

Antes de realizar qualquer depósito, consulte os Termos e condições de uso do repositório SciELO Data.

Repositorio de datos y otros materiales relacionados con artículos en proceso de evaluación para publicación o publicados por la Revista do Instituto de Medicina Tropical de São Paulo.

Antes de realizar cualquier depósito, consulte el Términos y condiciones de uso de SciELO Data.

Data and other materials repository related to articles under evaluation for publication or publicated by the journal Revista do Instituto de Medicina Tropical de São Paulo.

Before any deposit, consult the SciELO Data Terms and Conditions of Use.

Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

1 to 10 of 103 Results
Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"
Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"
Mar 17, 2025
Costa, Humberto Baptista; Lima, Filipe Rocha; Lima, Igor Gabriel Meneses; Brito, Sávio Breno Pires; Bitencourt, Julia; Arruda, Sérgio; Takenami, Iukary, 2025, "Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"", https://doi.org/10.48331/scielodata.GIP3HW, SciELO Data, V1
Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"
README_e24.pdf
README_e24.pdf
Mar 17, 2025 - Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"
Adobe PDF - 104.8 KB - MD5: a41f0a491698a4068a5469bc2b8497ba
rimtsp_e24_supl_mat.pdf
rimtsp_e24_supl_mat.pdf
Mar 17, 2025 - Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"
Adobe PDF - 290.5 KB - MD5: 9f4f9186d4e6bd4d1a751866499a814d
Supplementary Material of the Article "Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"
Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"
Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"
Jan 23, 2025
Bittencourt, Amanda Azevedo; Paula, Marina Della Negra de; Ribeiro-Pereira, Ana Carolina Padula; Batista, Paula de Mendonça; Polis, Thales José, 2025, "Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"", https://doi.org/10.48331/scielodata.AKHUWX, SciELO Data, V1
Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"
README_e7.pdf
README_e7.pdf
Jan 23, 2025 - Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"
Adobe PDF - 104.2 KB - MD5: e6a8e8a2ad3efcffabfc9ae87ee36dfb
rimtsp_e7_supl_mat.pdf
rimtsp_e7_supl_mat.pdf
Jan 23, 2025 - Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"
Adobe PDF - 804.2 KB - MD5: 007e6476da7bc566fbf31711e017744e
Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations"
Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"
Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"
Jan 8, 2025
Escobar-Laines, Sergio; Monteon, Victor; Ramírez-Sarmiento, Carlos; Macedo-Reyes, Verónica; Pérez, Floribeth León, 2025, "Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"", https://doi.org/10.48331/scielodata.FIMIZF, SciELO Data, V1
Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"
README_e5.pdf
README_e5.pdf
Jan 8, 2025 - Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"
Adobe PDF - 146.0 KB - MD5: 0f85670e528961c23ca18b98a4a062e0
rimtsp_e5_supl_mat.pdf
rimtsp_e5_supl_mat.pdf
Jan 8, 2025 - Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"
Adobe PDF - 705.3 KB - MD5: 35768bea270531ad716eb988bea4578e
Supplementary Material of the Article "Immunomodulatory effects of Triatoma dimidiata feces on Trypanosoma cruzi infection in a murine model"
Supplementary Material of the Article "Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals"
Supplementary Material of the Article "Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals"
Dec 9, 2024
Miyaji, Karina Takesaki; Ibrahim, Karim Yaqub; Infante, Vanessa; Moreira, Raquel Megale; Santos, Carolina Ferreira dos; Strabelli, Tânia Mara Varejão; Belizário, Juliana de Cássia; Pinto, Maria Isabel de Moraes; Marinho, Ana Karolina Barreto Berselli; Pereira, Juliana Marquezi; Mello, Liliane Saraiva de; Silva, Vitor Gabriel Lopes da; Sato, Paula Keiko; Ragiotto, Lucas; Pacheco, Pedro Henrique Theotonio de Mesquita; Braga, Patricia Emilia; Loch, Ana Paula; Precioso, Alexander Roberto; Sartori, Ana Marli Christovam, 2024, "Supplementary Material of the Article "Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals"", https://doi.org/10.48331/scielodata.4IGVTZ, SciELO Data, V1
Supplementary Material of the Article "Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals"
Add Data

Log in to create a dataverse or add a dataset.

Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.